Culturally respectful care starts at the very beginning of life, shaped by the rich lived experiences, traditions, and values that influence how children and families interact with the healthcare system. Every family brings unique circumstances, and clinicians and multidisciplinary teams …
Multiple sclerosis (MS) is a chronic, immune-mediated disease in which early, individualized disease-modifying therapy (DMT) can reduce disease activity, delay disability progression, and preserve quality of life. As therapeutic options expand—particularly multiple anti-CD20 therapies with different dosing schedules, administration routes, …
Retinal disease includes a wide array of conditions affecting the retina that, if not detected and treated early, can significantly impair quality of life, independence, and mobility while increasing the risk of accidental injury. These conditions also impose a substantial …
Culturally respectful care starts at the very beginning of life, shaped by the rich lived experiences, traditions, and values that influence how children and families interact with the healthcare system. Every family brings unique circumstances, and clinicians and multidisciplinary teams …
Lennox-Gastaut syndrome (LGS) affects every aspect of patients’ and caregivers’ lives, often far beyond seizures alone. Families face a fragmented system, where pediatric and adult care are poorly aligned, social services are hard to navigate, and long-term planning is unsupported. …
Generalized myasthenia gravis (gMG) disrupts neuromuscular transmission, creating unpredictable symptom flare-ups and placing a significant burden on patients with this rare condition. Most commonly associated with antibodies targeting the acetylcholine receptor (AChR), and less commonly with muscle specific kinase (MuSK) …
Generalized myasthenia gravis (gMG) disrupts neuromuscular transmission, creating unpredictable symptom flare-ups and placing a significant burden on patients with this rare condition. Most commonly associated with antibodies targeting the acetylcholine receptor (AChR), and less commonly with muscle specific kinase (MuSK) …
Despite major advances in inflammatory bowel disease (IBD) management, real-world data show that many patients continue to experience suboptimal outcomes due to misaligned treatment goals, therapeutic inertia, and limited integration of novel therapies, particularly IL-23 inhibitors—into individualized care plans. While …
Supporting the evolving needs of children and families takes a powerful, connected network of clinicians, schools, community partners, and service organizations. From ensuring physical safety and basic needs through child welfare services to providing team-based guidance for children with developmental …